Emerging evidence also implicates extracellular signal-regulated kinase 1/2 (ERK1/2) and the mechanistic target of rapamycin (mTOR), which operate downstream of TGF-β1 signaling, in renal fibrosis development [11,12], thus expanding our understanding of CKD pathophysiology. Here, MAPK3 is linked to chronic kidney disease.